Changes

Jump to navigation Jump to search
101 bytes removed ,  14:14, 22 October 2008
Line 49: Line 49:     
If a beta-lactamase inhibitor ('''Clavulanic acid''') is added to the drug formulation, the spectrum of most sub-groups is extended.
 
If a beta-lactamase inhibitor ('''Clavulanic acid''') is added to the drug formulation, the spectrum of most sub-groups is extended.
  −
• Addition of a beta-lactamase inhibitor (Clavulanic acid) broadens the spectrum of most sub-gps.
      
==Pharmacokinetic Considerations==
 
==Pharmacokinetic Considerations==
3,320

edits

Navigation menu